Skip to content

Adherence to Preventive Care for Cervical Cancer

Adherence to Screening and Follow-up Diagnostic and Treatment Services for Cervical Cancer Prevention

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02406391
Acronym
Adh-NYC-EP
Enrollment
400
Registered
2015-04-02
Start date
2015-04-30
Completion date
2017-12-31
Last updated
2015-04-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adherence, Cervical Cancer, Cervical Precancer

Brief summary

In the United States, the highest incidence of cervical cancer occurs in inner city urban centers, rural areas, the deep South, Appalachia and the U.S.-Mexico border. The goal of this study is to study predictors of adherence among patients seeking care at an inner city medical center in New York City and the U.S. Mexico border for cervical cancer prevention, namely, Pap smears and colposcopy exams.

Detailed description

Because there are multiple pathways through which a person is influenced to seek and receive care, the investigators will conduct interviews with patients seeking care for cervical cancer prevention at an inner city medical center. The investigators will ask questions related to previous screening, diagnostic, and treatment practices as well as barriers experienced in seeking such care. The investigators will also explore patients' level of resiliency and coping as predictors of adherence to timely care. Furthermore, among immigrants, questions about acculturation and discrimination will be asked. Additional measures of socioeconomic status, such as education, income and occupation will also be collected.

Interventions

None listed

Sponsors

Brookdale University Hospital Medical Center
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* women who are at least 21 years old * are seeking care for a Pap smear exam * are seeking care for a colposcopy exam for the first time * are not pregnant by self-report * are able to provide informed consent

Exclusion criteria

* women who do not meet the above eligibility criteria * women who have no prior history of a hysterectomy * women who have previously participated in this study

Design outcomes

Primary

MeasureTime frameDescription
Adherence to screening, colposcopy and follow-up treatment1-2 hour interview during clinic visit and review of patients' medical records during surveillance period (up to 2 years)A survey will be administered to patients who present for a routine Pap smear exam, a follow-up colposcopy exam. Medical records will be reviewed to document adherence to treatments post-colposcopy

Countries

United States

Contacts

Primary ContactLeonid Fradkin, PhD
lfradkin@bhmcny.org718-240-8225
Backup ContactThelma Carrillo
tcarrill@bhmcny.org718-240-5978

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026